Back to search
FDAFDA · Food and drugs·Recall number D-0403-2026

Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44

Published April 1, 2026 · Recall initiated: February 26, 2026

Summary

FDA records drug Class II recall D-0403-2026, published April 1, 2026 and initiated February 26, 2026. Recalling firm: MACLEODS PHARMA USA, INC; Status: Ongoing; Reported quantity: 1315 bottles; Lot: Lot 16240062A, exp date 3/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email if LEVOTHYROXINE SODIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LEVOTHYROXINE SODIUM
Manufacturer
MACLEODS PHARMA USA, INC
Distributor
Nationwide
UPC
0333342393104
Lot
Lot 16240062A, exp date 3/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44 recalled?

Yes. FDA published recall D-0403-2026 on April 1, 2026. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LEVOTHYROXINE SODIUM. UPC: 0333342393104.